[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604294":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":19,"locations":25,"responsibleParty":43,"collaborators":11,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":11,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":11,"enrollmentInfo":54,"targetDuration":11,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":27,"whyStopped":11,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Select Eye Care","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Direct Selective Laser Trabeculoplasty","EXPERIMENTAL",null,[13],"Device: Direct Selective Laser Trabeculoplasty",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"DEVICE","DSLT using the Belkin Vision Eagle Device",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":11,"email":24},"Scott E LaBorwit, MD","CONTACT","410-821-6400","scott.laborwit@vipeyes.com",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Elkridge","Maryland","21075","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-76.71358,39.21261,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":23,"phoneExt":11,"email":42},"Research Coordinator","hshea@vipeyes.com",{"type":44,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100604294","direct-selective-laser-trabeculoplasty-dslt-for-reducing-eye-pressure-in-non-caucasian-patients-with-open-angle-glaucoma-100604294",false,"NCT07147647","Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma","Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients","Inclusion Criteria:\n\n* Adult patients of Black African descent scheduled to undergo DSLT treatment in one or both eyes.\n* Diagnosis of mild to moderate primary open angle glaucoma (POAG).\n* Mild to moderate POAG will be defined as Stage 2 or better of the Hodapp-Anderson-Parrish glaucoma staging system.\n* Treatment naive or washed out IOP at time 0 ranging from ≥ 21 through 32 mm Hg.\n\nExclusion Criteria:\n\n* Screened patients who were on IOP-lowering medications who did not successfully complete medication washout at the time of the procedure (time 0).\n* Previous glaucoma surgeries\u002Finterventions:\n* Patients who have undergone prior glaucoma-related procedures (e.g., trabeculectomy, laser trabeculoplasty, MIGS, or tube shunt).\n* Secondary glaucoma:\n* Patients with secondary forms of glaucoma, such as angle-closure glaucoma, neovascular glaucoma, or glaucoma resulting from trauma or other systemic diseases.\n* Other significant ocular conditions including advanced cataracts, retinal diseases (e.g., age-related macular degeneration), or any condition that might complicate the assessment of intraocular pressure (IOP) or visual function as deemed by the investigator.\n* Subjects who are pregnant, breast-feeding, or intend to become pregnant during the study period as determined by verbal inquiry.","ALL","18 Years",{"count":55,"type":56},60,"ESTIMATED","INTERVENTIONAL",[59],"NA","The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is:\n\nWhat is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure.\n\nParticipants will:\n\nUndergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.",[62],"Primary Open Angle Glaucoma (POAG)",[9,64,65,66,67],"DSLT","Primary Open Angle Glaucoma","POAG","Glaucoma","2025-08-22",{"date":70,"type":71},"2025-08-29","ACTUAL",{"date":73,"type":71},"2025-07-16",{"date":75,"type":56},"2026-10",{"name":5,"class":6},1]